enfortumab,Pembrolizumab,cisplatin,carboplatin,gemcitabine
Astellas,Merck,Seagen
['pembro', 'muc ,(-much)', 'seagen', 'astellas']
#asco23 brings you long-term outcome of ev+pembro in 1l cis-ineligible muc with 4 years of follow up from . hall d1 at 11:30am 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.